(1)
NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES. JUSR 2025, 1 (Maxsus son (FARMAKOLOGIYA, FARMATSEVTIKA), 86-86.